Prostate-specific antigen and radiolabelled choline PET/CT   for the assessment of response to therapy: synergy or conflicting?
Radiotherapy and Nuclear Medicine Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy. laura.evangelista@tin.it.
Laura
L
Evangelista
Nuclear Medicine Department, Humanitas Gavazzeni, Bergamo, Italy.
Emilio
E
Bombardieri
D001692:Biological Transport; D002250:Carbon Radioisotopes; D002794:Choline / Q000378:metabolism; D018450:Disease Progression; D006801:Humans; D008297:Male; D064847:Multimodal Imaging; D049268:Positron-Emission Tomography; D017430:Prostate-Specific Antigen / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging / Q000378:metabolism / Q000628:therapy*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D002250:Carbon Radioisotopes; D017430:Prostate-Specific Antigen; D002794:Choline